With TIS I've learned over the last couple of years not to get too concerned when timelines are stated and then not met. When the news does come it is so encouraging that I can overlook delays. Let's face it, the commercialisation announcement was originally slated for March. I have little doubt it will come, as will the results, and when it does we will not be disappointed we had to wait.
My opinion only.
Rev
TIS Price at posting:
56.5¢ Sentiment: Buy Disclosure: Held
